elocom krém
n.v. organon, holandsko - mometazón - 46 - dermatologica
elocom roztok
n.v. organon, holandsko - mometazón - 46 - dermatologica
ichtoxyl
herbacos recordati s.r.o., Česká republika - dechty - 46 - dermatologica
azatril
alvogen pharma trading europe eood, bulharsko - azitromycín - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)
advantan masť
leo pharma a/s , dánsko - metylprednizolónaceponát - 46 - dermatologica
advantan krém
leo pharma a/s , dánsko - metylprednizolónaceponát - 46 - dermatologica
advantan mastný krém
leo pharma a/s , dánsko - metylprednizolónaceponát - 46 - dermatologica
beloderm lotion
belupo, s.r.o., slovensko - betametazón - 46 - dermatologica
veregen 100 mg/g masť
nordic pharma, s.r.o., Česká republika - sinekatechíny - 46 - dermatologica
azacitidine celgene
celgene europe bv - azacitidín - myelodysplastic syndromes; leukemia, myelomonocytic, chronic; leukemia, myeloid, acute - antineoplastické činidlá - azacitidine celgene is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (hsct) with:intermediate 2 and high-risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),chronic myelomonocytic leukaemia (cmml) with 10 29 % marrow blasts without myeloproliferative disorder,acute myeloid leukaemia (aml) with 20 30 % blasts and multi-lineage dysplasia, according to world health organisation (who) classification,aml with >30% marrow blasts according to the who classification.